Scott Canna, M.D.
Scott Canna received his undergraduate degree from Johns Hopkins University and his medical degree from the George Washington University School of Medicine. During medical school he participated in the Clinical Research Training Program here at NIAMS under Dr. Goldbach-Mansky. He completed a pediatrics residency at Children's Hospital Colorado in 2009, and a pediatric rheumatology fellowship at The Children's Hospital of Philadelphia in 2012. Prior to joining NIAMS in 2013 as a Metzger Clinical Scholar, he completed a postdoctoral fellowship in Edward Behrens’ laboratory developing animal models of Macrophage Activation Syndrome (MAS). His research interests include basic and translational research on the pathogenesis of MAS, hemophagocytic lymphohistiocytosis (HLH) and related cytokine storm disorders.
Cornelia Cudrici, M.D.
Cornelia Cudrici received her Medical degree from the Iuliu Hatieganu University of Medicine and Pharmacy, in Cluj-Napoca, Romania. She completed Internal Medicine residency training at Rochester General Hospital, Rochester, NY, and completed Rheumatology Fellowship training at the NIH in 2013. She has also been named a NIAMS Lawrence Shulman Scholar. Her research interests include anti-inflammatory effects of disease-modifying antirheumatic drugs, and pathogenesis and treatment of autoinflammatory diseases.
Pravitt Gourh, M.D.
Pravitt Gourh received his medical degree (MBBS) from the Baroda Medical College, Maharaja Sayajirao University, India. He went to Texas Tech University Health Sciences Center (HSC) for graduate school and then joined the University of Texas HSC (UTHSC) at Houston as a research associate, where he was soon promoted to Assistant Professor of Medicine. AT UTHSC, he studied the genetics of scleroderma and conducted candidate gene studies and a genome wide association study in scleroderma. He completed his Internal Medicine residency training at UTHSC in 2012, and the joined the NIAMS rheumatology fellowship training program, which he completed in 2014. He subsequently was promoted to Henry Metzger Scholar in Translational Medicine at the NIAMS. His current research is focused on understanding the genetics of both pediatric and adult scleroderma, and protein biomarker discovery. One of his current projects involves a multi-center collaboration across the United States to perform whole exome sequencing, and a genome wide association study involving the largest cohort of African-American scleroderma patients. He has received multiple awards, including the Carwile Leroy/Joseph Korn Prize for Research in Scleroderma, the Young Investigator Award at the 10th International Systemic Sclerosis Workshop, the American Academy of Rheumatology (ACR) Research and Education Abbott Medical and Pediatric Resident Research Award, the ACR Rheumatology Research Workshop Outstanding Abstract award, and the 33rd European Workshop for Rheumatology Research Travel Award. He has given presentations both nationally and internationally.
Sarthak Gupta, M.D.
Sarthak Gupta received his medical degree from Jawaharlal Nehru Medical College, Aligarh, India, and completed a residency in Internal Medicine at the State University of New York at Buffalo. During his medical school and residency he, worked on autoimmune diseases of the skin and anti-phospholipid syndrome, and in the lab, helped identify novel autoantigens in a mouse model of Sjogren's disease. He moved to the NIAMS/NIH to pursue a three-year adult rheumatology fellowship in 2011 and also served as the Chief Fellow for the training program. He is currently a Henry Metzger Scholar in Translational Medicine and works with Dr. Sarah Browne and Dr. Steven Holland in NIAID, and Dr. Richard Siegel in NIAMS. His research helps define the spectrum and activity of anticytokine autoantibodies in autoimmune diseases. In addition, he is an associate investigator in the STOP LUPUS study evaluating Omalizumab therapy in patients with Lupus.
Hanna Kim, M.D.
Hanna Kim received her undergraduate degree from California Institute of Technology (Caltech) and her medical degree from the University of California at Irvine (UCI). She completed residence in Pediatrics at George Washington University / Children’s National Medical Center. She completed a pediatric rheumatology fellowship at Nemours/Alfred I. DuPont Hospital for Children, Children’s National Health System, and NIAMS. She has been awarded the Earl J. Fellow Research Award from the American Academy of Pediatrics, Rheumatology Research Foundation Marshall J. Schiff Memorial Fellow Research Award, and American College of Rheumatology Distinguished Fellow Award. She was subsequently promoted to Lawrence Shulman Scholar in Pediatric Translational Medicine at NIAMS. Her current research interest is pathogenesis and biomarker discovery in juvenile dermatomyositis by comparison with Mendelian autoinflammatory diseases.
Laura Lewandowski, M.D.
Laura Lewandowski received her undergraduate degree from the College of the Holy Cross in Worchester, Massachusetts, and her medical degree from Pennsylvania State University College of Medicine. She completed pediatric residency training at the University of Massachusetts Medical Center, where she also served as a chief resident in pediatrics, and developed a program in Global Health training. She completed a combined four-year pediatric rheumatology/ global health fellowship at Duke University Medical Center, during which she characterized a pediatric lupus patient cohort in South Africa. She holds a Masters in Global Health from Duke University, as well. She was awarded a Fogarty Global Health Fellowship and a Lupus Foundation Early Career award for her work with pediatric lupus patients in South Africa. In 2015, she joined the NIAMS under Dr. Mariana Kaplan as a Lawrence Shulman Scholar in Translational Medicine. Her current research interests include clinical and translational research in pediatric systemic lupus erythematosus (SLE), with a focus on markers of inflammation and gene expression profiling for pediatric SLE patients in varied cohorts around the world.
Daniella M. Schwartz, M.D.
Daniella M. Schwartz received her undergraduate degree from Rice University (cum laude) and her medical degree from the Wake Forest University School of Medicine (Alpha Omega Alpha). She completed an internal medicine residency at Virginia Commonwealth University where she also served as a chief resident. She joined NIAMS in 2012 as a clinical rheumatology fellow and was subsequently promoted to Henry Metzger Scholar in Translational Medicine. Her research interests include basic and translational research on epigenetic regulation of CD4+ T cell lineage commitment with a focus on retinoic acid as an epigenetic immunomodulator.
Keith Sikora, M.D.
Keith Sikora received his undergraduate degree from Cornell University and his medical degree from SUNY at Buffalo School of Medicine and Biomedical Sciences. After pediatric residency at The Johns Hopkins Hospital, he completed his pediatric rheumatology fellowship at Cincinnati Children's Hospital Medical Center, where he also studied the pathogenesis of systemic juvenile idiopathic arthritis. Dr. Sikora joined Dr. Robert Colbert's group in 2012 as a Metzger Scholar, where he pursues his interests of investigating the pathogenic role of the myeloid lineage in spondyloarthropathies and associated forms of autoinflammatory disease.